Advertising & Promotional Review

ProPharma has built the world’s leading and first, full-service organization dedicated to global Advertising, Promotional Review, & Labeling Services.

Explore our Services
global-medical-writing-transparency-header-banner global-medical-writing-transparency-header-banner

Flexible MLR Support. Immediate Operational Relief. End-to-End Compliance.

When promotional demands increase or internal bandwidth is stretched, you need more than advice, you need experienced professionals who can step in immediately and keep your review process moving.

ProPharma provides scalable advertising and promotional review services designed to:

  • Fill urgent MLR staffing gaps
  • Support high-volume review periods
  • Strengthen governance and compliance
  • Deliver fully outsourced promotional review operations

Whether you require short-term operational relief or comprehensive end-to-end MLR support, our experts integrate seamlessly with your team.

Why Sponsors Choose ProPharma for Advertising & Promotional Review

When promotional timelines are compressed and regulatory scrutiny is increasing, sponsors need more than reviewers, they need experienced partners who understand both compliance risk and commercial urgency.

ProPharma stands apart because we combine strategic regulatory expertise with operational execution, allowing us to support clients at every stage of promotional development.

Our clients choose to work with our team of expert Advertising & Promotional Review experts time and time again for the following reasons: 

Partner with us!

Deep Regulatory & Industry Expertise

Our team brings deep experience supporting clients across the product lifecycle. With strong expertise in FDA advertising regulations, OPDP expectations, and evolving enforcement trends, we help sponsors proactively manage promotional risk across traditional and digital channels.

Rapid Operational Relief & Seamless Integration

When teams face staffing gaps, leave coverage, launch surges, or high-volume review periods, we deploy experienced MLR professionals quickly. Our experts integrate directly into your workflows, functioning as a true extension of your internal team to ensure continuity and efficiency. 

Strategic Governance + Hands-On Execution

We don’t just advise, we execute. From MLR process design and SOP optimization, to day-to-day promotional material review and PRC support, our team strengthens governance while keeping materials moving through the review process efficiently. 

Scalable, End-to-End Promotional Review Solutions

Whether you need targeted team augmentation or a fully outsourced promotional review model, we have designed our flexible engagement structure to align with your organization’s size, risk tolerance, and commercial timelines. 

Fill Your MLR Gaps. Strengthen Compliance. Move Faster.

Connect with an Expert

ProPharma's Advertising & Promotional Review Services

Service icon

Team Augmentation

Team Augmentation

Pin leading to another pin icon

End-to-End Solutions

End-to-End Solutions

Spinning cog icon

Marketing Operations

Marketing Operations

Immediate MLR & Promotional Review Team Augmentation

Need to backfill a regulatory reviewer? Cover parental leave? Manage a surge in promotional materials before launch?

We deploy seasoned Medical, Legal, and Regulatory (MLR) professionals quickly, minimizing disruption and maintaining compliance continuity.

Our team augmentation services include:

  • Regulatory and medical promotional reviewers
  • Interim MLR leadership and governance oversight
  • Promotional Review Committee (PRC/MLR) meeting support
  • Submission and Form FDA 2253 support
  • High-volume promotional material review
  • Social media and digital promotion review support

We function as a true extension of your internal team, not just external consultants.

Partner With Us
Several business professionals smiling at a business meeting

Fully Outsourced & End-to-End Promotional Review Solutions

For organizations seeking broader support, ProPharma delivers comprehensive promotional review and advertising compliance services across the full lifecycle.

Our capabilities include:

  • MLR Process Design & Optimization: Governance framework development, SOP refinement, KPI tracking, and workflow optimization.
  • End-to-End Promotional Material Review: Medical, regulatory, and risk assessment across print, digital, broadcast, social media, influencer, and emerging promotional channels.
  • Promotional Risk Mitigation Strategy: Proactive alignment with evolving FDA expectations, OPDP enforcement trends, and industry best practices.
  • Launch & High-Growth Support: Scalable infrastructure to support product launches, expanded indications, and new promotional channels.

Our engagement model is flexible, from targeted operational support to fully managed promotional review programs tailored to your organization’s structure and risk tolerance.

Connect with an MLR Expert
Business worker collaborating around a blackboard

Marketing Operations & MLR Process Management

Effective promotional compliance depends on strong operational infrastructure. ProPharma provides marketing operations and MLR process management support to ensure your promotional review function runs efficiently, consistently, and in alignment with governance expectations.

Whether you need to build infrastructure from the ground up or optimize an existing framework, our team delivers scalable operational support.

  • Commercial Operations Infrastructure: Development and refinement of policies, processes, and SOPs to support compliant and efficient promotional review workflows.
  • MLR/PRC Process Management: Experienced PRC Coordinators who manage review workflows, facilitate cross-functional alignment, track approvals, and maintain documentation integrity.
  • Cross-Functional Collaboration Support: Dedicated resources that improve coordination across Medical, Legal, Regulatory, and Commercial teams to reduce bottlenecks and accelerate review cycles.
  • eReview System Implementation & Optimization: Implementation and configuration of promotional review systems to enhance visibility, tracking, and audit readiness.
  • Experience Across Leading eReview Platforms: Hands-on experience across major promotional review technologies, enabling seamless integration into your existing systems.

The result: a streamlined, well-governed MLR process that supports speed, transparency, and sustained compliance.

Speak with a Marketing Operations Expert
Business professionals collaborating in an office around a laptop
Thumbnail Image for Simplifying Global MLR Review: Local Expertise at a Global Scale

Simplifying Global MLR Review: Local Expertise at a Global Scale

Struggling to streamline MLR review across international markets? Discover how our team helped a leading pharmaceutical company reduce review timelines, ensure regulatory compliance, and eliminate vendor fragmentation—across Korea, Japan, Brazil, Europe, and beyond. Download the...

Download Now

ProPharma: The World's Leading Regulatory Consultancy

ProPharma’s team of advertising and promotional review consultants can help with all of your advertising and product promotion-related needs. Contact us today to learn about our track record of success with the regulatory agencies over the last 40 years and discuss how we can help you get to the next regulatory milestone.

Partner With Us

News & Insights

Thought Leadership Webinars Press Awards Resource Library
When AI Meets CGMP: Lessons from FDA's First Warning Letter on Non-Compliant AI Use in Manufacturing

April 22, 2026

When AI Meets CGMP: Lessons from FDA's First Warning Letter on Non-Compliant AI ...

The FDA's warning letter to Purolea Cosmetics Lab highlights the need for rigorous AI governance in pharmaceutical manufacturing. Compliance is crucial for product quality and safety.

Read Full Article
Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Global Market Reach

April 20, 2026

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Gl...

Explore the benefits of offshoring medical information services, enhancing global support and operational flexibility for healthcare and pharmaceutical companies.

Read Full Article
Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

April 16, 2026

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

Prepare for EMA Policy 0070 by understanding anonymization requirements, project management strategies, and best practices to ensure a smooth submission process.

Read Full Article
View all Thought Leadership
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

Read Full Article
ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

Read Full Article
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Read Full Article
View all Press
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Read Full Article
ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

Read Full Article
ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Read Full Article
View all Awards
Case Study Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemophilia Gene Therapy Trial

April 20, 2026

Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemoph...

Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on...

Read Full Article
Case Study Ensure Launch Readiness—Even on the Tightest Timelines

March 30, 2026

Ensure Launch Readiness, Even on the Tightest Timelines

Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...

Read Full Article
Case Study How a Novel Real World Evidence Strategy Helped Bring a Class III Device to Market - ProPharma

March 23, 2026

Real World Evidence for Class III Devices: A Smarter Path to PMA

Struggling to generate clinical evidence for Class III devices without costly, multi-year trials? Discover how ProPharma helped an orthopedic device company leverage existing registry data to support...

Read Full Article
View all Resources
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Register
Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

Watch the Replay
EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Watch the Replay
View all Webinars

News & Insights

When AI Meets CGMP: Lessons from FDA's First Warning Letter on Non-Compliant AI Use in Manufacturing

April 22, 2026

When AI Meets CGMP: Lessons from FDA's First Warning Letter on Non-Compliant AI ...

The FDA's warning letter to Purolea Cosmetics Lab highlights the need for rigorous AI governance in pharmaceutical manufacturing. Compliance is crucial for product quality and safety.

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Global Market Reach

April 20, 2026

Offshoring Medical Information Services: A Breakthrough Trend to Achieve 24/7 Gl...

Explore the benefits of offshoring medical information services, enhancing global support and operational flexibility for healthcare and pharmaceutical companies.

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

April 16, 2026

Preparing for EMA Policy 0070: How to Stay Ahead of the Anonymization Curve

Prepare for EMA Policy 0070 by understanding anonymization requirements, project management strategies, and best practices to ensure a smooth submission process.

Previous Post Arrow Next Post Arrow
ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

January 27, 2026

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero T...

ProPharma’s greenhouse gas reduction targets are validated by SBTi, aligning with the Net-Zero Standard and a commitment to reach net-zero by 2050.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemophilia Gene Therapy Trial

April 20, 2026

Reducing Patient Burden While Maintaining High-Frequency Monitoring in a Hemoph...

Balancing rigorous clinical oversight with patient accessibility is critical in complex gene therapy trials. Intensive early-phase monitoring and complex protocols can place significant burden on...

Case Study Ensure Launch Readiness—Even on the Tightest Timelines

March 30, 2026

Ensure Launch Readiness, Even on the Tightest Timelines

Expediting Promotional Review to Deliver 60+ Materials in Just 4 Weeks When timelines are compressed and stakes are high, promotional review processes can quickly become a bottleneck. This case study...

Case Study How a Novel Real World Evidence Strategy Helped Bring a Class III Device to Market - ProPharma

March 23, 2026

Real World Evidence for Class III Devices: A Smarter Path to PMA

Struggling to generate clinical evidence for Class III devices without costly, multi-year trials? Discover how ProPharma helped an orthopedic device company leverage existing registry data to support...

Previous Resource Arrow Next Resource Arrow
Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

June 2, 2026

Foundations of a Compliant EU–UK GMP–GDP Supply Chain: From Importation to Distribution

A compliant and efficient EU–UK GMP–GDP supply chain requires a clear understanding of roles, responsibilities, and operational integration across importation, certification, and distribution...

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

April 23, 2026

Clinical Promise to Commercial Reality: The Path to Cell & Gene Therapy Market

As cell and gene therapies transition from clinical development to commercialization, organizations face evolving regulatory expectations, expanded CMC requirements, and increased MAH...

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

April 9, 2026

EMA Policy 0070: Advanced Strategies for Compliance, Anonymization, and CCI Justification

As European Medicines Agency Policy 0070 enters its expanded Step 2 phase, sponsors face increased document volumes, heightened transparency obligations, and greater scrutiny of anonymization and CCI...

Previous Webinar Arrow Next Webinar Arrow